Search Results 1301-1310 of 17135 for Birth Control Evolution

  1. S0820, Adenoma and Second Primary Prevention Trial - Mayo Clinic

    At least 30 days from completion of adjuvant chemo. Presence of gastroesophageal reflux disease acceptable if controlled with medications; Not receiving or ...

  2. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

    Inability to swallow pills; Bleeding diathesis; New diagnosis of carcinoma; History of hypersensitivity to COX-2 inhibitors, sulfonamides, nonsteroidal ...

  3. A Study Investigating Coagadex In The Treatment AFXD Associated With AL Amyloidosis - Mayo Clinic

    Woman of Childbearing Potential (defined in Appendix 2) and men of reproductive potential who agree to use an effective contraception measure during the study.

  4. A Study to Evaluate Postpartum Recovery After Cesarean Delivery Using the Obstetric Quality of Recovery Tool - Mayo Clinic

    The purpose of this study is to describe the course of recovery over the first 3 months after elective cesarean delivery. Participation eligibility. Participant ...

  5. Pediatrics Clinical Trials - Medical Professionals

    More than two thirds of affected infants have other birth defects that include other parts of the gastrointestinal tract, airway, heart, skeleton, kidneys, eyes ...

  6. Establishment of Preclinical Models from Patients with Gynecological Malignancies - Mayo Clinic

    In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...

  7. Medical Research & Education - Mayo Clinic News Network

    ... population health. Latest stories. Research. Mayo researchers studying ... Pain management for older adults: Mayo Clinic Radio featured image. Health & Wellness.

  8. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

    All heterosexually active FCBP and all heterosexually active male patients must agree to use effective methods of birth control throughout the study.

  9. A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant ...

  10. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission - Mayo Clinic

    Women of childbearing potential and sexually active males must use an accepted and effective method of contraception. Patients of known East Asian ancestry ...